BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21093024)

  • 1. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation.
    Meltzer EO; Busse WW; Wenzel SE; Belozeroff V; Weng HH; Feng J; Chon Y; Chiou CF; Globe D; Lin SL
    J Allergy Clin Immunol; 2011 Jan; 127(1):167-72. PubMed ID: 21093024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and agreement across four versions of the asthma control questionnaire in patients with persistent asthma.
    Wyrwich KW; Khan SA; Navaratnam P; Nolte H; Gates DF
    Respir Med; 2011 May; 105(5):698-712. PubMed ID: 21146389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.
    Juniper EF; Bousquet J; Abetz L; Bateman ED;
    Respir Med; 2006 Apr; 100(4):616-21. PubMed ID: 16226443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast for mild and exercise-induced asthma.
    Adelman A
    J Fam Pract; 1998 Nov; 47(5):335. PubMed ID: 9834763
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
    Pharmacoeconomics; 1999; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
    Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
    Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of methacholine challenges in a multicenter pediatric asthma study.
    Covar RA; Colvin R; Shapiro G; Strunk R
    J Allergy Clin Immunol; 2006 Mar; 117(3):709-11. PubMed ID: 16522478
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with the control of severe asthma.
    Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL
    J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bronchial thermoplasty in asthma: an updated review].
    Torrego Fernández A
    Arch Bronconeumol; 2010 Jul; 46(7):397. PubMed ID: 20378232
    [No Abstract]   [Full Text] [Related]  

  • 11. Tapering inhaled steroids effective for chronic asthma.
    See S; Rubin S
    J Fam Pract; 2003 Oct; 52(10):748-51. PubMed ID: 14529591
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which inhaled corticosteroid for asthma?
    Wilson SA
    J Fam Pract; 1999 Sep; 48(9):658-9. PubMed ID: 10498062
    [No Abstract]   [Full Text] [Related]  

  • 14. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
    Camargo CA; Boulet LP; Sutherland ER; Busse WW; Yancey SW; Emmett AH; Ortega HG; Ferro TJ
    J Asthma; 2010 Feb; 47(1):76-82. PubMed ID: 20100025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group.
    Control Clin Trials; 1999 Feb; 20(1):91-120. PubMed ID: 10027502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cromolyn use in children with asthma.
    Graber MA
    J Fam Pract; 1998 Feb; 46(2):113-4. PubMed ID: 9487311
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity.
    Mahut B; Trinquart L; Le Bourgeois M; Becquemin MH; Beydon N; Aubourg F; Jala M; Bidaud-Chevalier B; Dinh-Xuan AT; Randrianarivelo O; Denjean A; de Blic J; Delclaux C
    Allergy; 2010 May; 65(5):636-44. PubMed ID: 19845572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asthma patients with allergic rhinitis, To treat airways as a whole!].
    MMW Fortschr Med; 2005 Feb; 147(8):57. PubMed ID: 18437863
    [No Abstract]   [Full Text] [Related]  

  • 19. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
    Holgate S; Bousquet J; Wenzel S; Fox H; Liu J; Castellsague J
    Curr Med Res Opin; 2001; 17(4):233-40. PubMed ID: 11922396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.